US Broker Ratings

Elevance Health, Inc. (ELV) Stock Analysis: Navigating a Competitive Healthcare Landscape with Strong Buy Ratings

Elevance Health, Inc. (NYSE: ELV), a formidable player in the healthcare sector, continues to command investor attention with its diversified offerings and strategic positioning in the healthcare plans industry. With..

Stryker Corporation (SYK) Stock Analysis: A Healthcare Giant with 27.57% Upside Potential

Stryker Corporation (NYSE: SYK), a heavyweight in the healthcare sector, is a medical devices juggernaut with a market capitalization of $117.18 billion. Headquartered in Portage, Michigan, Stryker has carved a..

Baxter International Inc. (BAX): Investor Outlook Shows 11.15% Potential Upside Amid Healthcare Sector Dynamics

Baxter International Inc. (NYSE: BAX), a stalwart in the healthcare sector, continues to present intriguing opportunities for investors navigating the medical instruments and supplies industry. With a market capitalization of..

Johnson & Johnson (JNJ) Stock Analysis: Navigating Growth with a 9.90% Revenue Surge and an 8.63% Potential Upside

Investors eyeing Johnson & Johnson (NYSE: JNJ) will find a resilient healthcare giant poised for continued growth. With a market capitalization of $560.33 billion, J&J stands as a stalwart in..

United Therapeutics Corporation (UTHR) Stock Analysis: Investor Outlook on Robust Growth Potential with 20.98% Upside

United Therapeutics Corporation (NASDAQ: UTHR) continues to intrigue investors with its innovative approach to treating chronic and life-threatening diseases. As a key player in the healthcare sector, United Therapeutics specializes..

Mettler-Toledo International (MTD) Stock Analysis: A 15% Upside Potential in Diagnostics & Research

Mettler-Toledo International Inc. (NYSE: MTD), a titan in the precision instruments sector, offers an intriguing proposition for investors with its robust growth potential and strategic market positioning. Headquartered in Greifensee,..

Summit Therapeutics Inc. (SMMT) Investor Outlook: Exploring a Potential 91.97% Upside

Summit Therapeutics Inc. (NASDAQ: SMMT) has emerged as a notable player in the biotechnology sector, particularly for investors keeping a keen eye on high-growth potential stocks. Based in Miami, Florida,..

Vertex Pharmaceuticals (VRTX) Stock Analysis: Uncovering a 22.80% Potential Upside

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), a leading player in the biotechnology sector, continues to captivate investor interest with its robust growth trajectory and expansive product pipeline. With a market capitalization..

McKesson Corporation (MCK) Stock Analysis: Exploring a 22.44% Potential Upside with Strong Buy Ratings

McKesson Corporation (NYSE: MCK) stands as a formidable player in the healthcare sector, operating within the medical distribution industry. With a market capitalization of $93.24 billion, McKesson is a key..

Veeva Systems Inc. (VEEV) Stock Analysis: Unveiling a 43.84% Potential Upside in the Healthcare Cloud Software Sector

Veeva Systems Inc. (VEEV) stands as a formidable player in the healthcare technology sector, offering a suite of cloud-based software solutions primarily aimed at the life sciences industry. With a..

argenx SE (ARGX)

⚠️ No article content returned.

..

Sanofi (SNY) Stock Analysis: Unveiling a 24% Upside Amid Robust Dividend Yield

Sanofi (NASDAQ: SNY), a pharmaceutical giant headquartered in Paris, France, continues to capture investor interest with its promising potential upside and robust dividend yield. The company, a leader in the..

Waters Corporation (WAT) Stock Analysis: Insights into a Healthcare Giant with a 9.56% Upside Potential

Waters Corporation (NYSE: WAT), a prominent player in the healthcare sector, specializes in diagnostics and research technology, particularly in the realms of liquid chromatography and mass spectrometry. Headquartered in Milford,..

AbbVie Inc. (ABBV) Stock Analysis: Exploring a Promising 11.58% Upside Potential

AbbVie Inc. (NYSE: ABBV), a powerhouse in the healthcare sector, is capturing investor attention with its robust market presence and compelling growth prospects. As a leading player in the drug..

Amgen Inc. (AMGN) Stock Analysis: Evaluating Its 0.76% Upside Potential Amid Strong Revenue Growth

Amgen Inc. (NASDAQ: AMGN), a titan in the healthcare sector, is a leading player in the drug manufacturing industry with a market capitalization of $188.67 billion. Known for its extensive..

CVS Health Corporation (CVS) Stock Analysis: A 7.41% Potential Upside with Strong Analyst Support

CVS Health Corporation (NYSE: CVS), a titan in the healthcare sector, is capturing investor attention with its robust market presence and potential upside. With a market capitalization of $122.4 billion..

Pfizer, Inc. (PFE) Stock Analysis: Exploring a 12% Potential Upside Amid Robust Free Cash Flow and Strong Dividend Yield

Pfizer Inc. (NYSE: PFE), a titan in the healthcare sector, continues to attract investor attention with its robust market presence and a portfolio of biopharmaceutical products that cater to a..

Edwards Lifesciences Corporation (EW) Stock Analysis: 12.75% Potential Upside with Robust Revenue Growth

Edwards Lifesciences Corporation (NYSE: EW) stands out in the healthcare sector, particularly within the medical devices industry, as a leader in cardiovascular disease treatment technologies. With a formidable market capitalization..

Thermo Fisher Scientific (TMO) Investor Outlook: Assessing a 27% Potential Upside Amidst Strong Buy Ratings

Thermo Fisher Scientific Inc. (NYSE: TMO), a prominent player in the healthcare sector, particularly in the diagnostics and research industry, is drawing considerable attention from investors due to its robust..

Abbott Laboratories (ABT) Investor Outlook: Harnessing a 28.79% Potential Upside

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector, has long been a favorite among investors for its stability and innovation. With a market capitalization of $158.63 billion, Abbott..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds